Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation

NCT05776797 is registered in ClinicalTrials.gov with University Hospital Ostrava as lead sponsor.

NCT NCT05776797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05776797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation
Lead sponsor
University Hospital Ostrava
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2023
Completion date
March 31, 2029
Enrollment
480 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation, recurrent atrial fibrillation